A RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF MODIFIED JATYADI GHRUTA - SPRAY IN THE MANAGEMENT OF DUSHTA VRANA
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
研究概览
简要总结
In India, chronic wounds affect approximately 1.89 per 1,000 individuals, with a slightly higher prevalence in rural areas compared to urban regions. Ayurveda, particularly the classical text Sushruta Samhita, emphasizes the importance of wound management (Vrana) and describes Shasti Upakrama-sixty therapeutic procedures for treating wounds using cleansing (Shodhana) and healing (Ropana) methods.
Jatyadi Ghruta, described in Bhaishajya Ratnavali, is a traditional ghee-based polyherbal formulation containing eleven herbal ingredients and is widely used for treating Dushta Vrana (chronic or infected wounds). Its components possess antimicrobial, anti-inflammatory, and antiseptic properties, which support wound healing.
To improve practicality and patient compliance, Jatyadi Ghruta can be transformed into a spray formulation. This modification makes the application easier, more hygienic, and suitable for large or sensitive wounds by avoiding direct contact and reducing contamination risk. The spray also provides a cooling and soothing effect, enhancing comfort for inflamed or ulcerated skin.
Thus, the spray formulation combines traditional Ayurvedic knowledge with modern pharmaceutical approaches to improve wound care effectiveness and usability.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- All
入选标准
- •1.Patients with lakshanas of Dustha Vrana (more than 1 month).
- •2.Patient of either sex in the age group of 18 to 60 years.
- •3.All types of non specific ulcer.
- •4.Patients with controlled systematic disease.
- •5.Patients pre diagnosed diabetes mellitus with HbAlc less than 6 or 6.
排除标准
- •1.Patients having complications like malignancy, gangrene, leprosy, TB wound, osteomyelitic ulcer.
- •2.Pregnant and lactating women will be excluded.
- •3.Patients with H.I.V, HbsAg, HCV.
- •Patients with uncontrolled systemic diseases.
研究者
DR ANUSHA PERUR
Muniyal institute of ayurveda medical sciences, Manipal
